Solve with reason
Answer: B. Congestive Heart Failure (CHF)
Systematic Reasoning
Patient profile: 60-year-old male with prior MI and hypertension — both are the leading causes of CHF.
| Finding | Significance |
|---|---|
| Progressive dyspnea | Reduced cardiac output → pulmonary congestion |
| Chronic cough | Pulmonary edema (cardiac cough) |
| Bilateral leg swelling + pitting pedal edema | Right heart failure → systemic venous congestion |
| Fatigue | Low cardiac output state |
| Raised JVP | Right-sided heart failure / fluid overload — hallmark sign |
| Bibasal crackles | Pulmonary edema from left heart failure |
| Previous MI | Ischemic cardiomyopathy → systolic dysfunction |
| Hypertension | Pressure overload → diastolic/systolic dysfunction |
Why the other options are wrong
- A. COPD — Would present with barrel chest, prolonged expiration, wheeze, and smoking history. Raised JVP and pitting edema suggest cardiac, not purely pulmonary, etiology. No mention of obstructive features.
- C. Nephrotic syndrome — Causes edema but via hypoalbuminemia (non-pitting or generalized). No proteinuria, hypoalbuminemia, or hyperlipidemia mentioned. JVP would be low/normal, not raised.
- D. Pneumonia — Causes fever, productive cough, consolidation on exam. Bilateral leg swelling and raised JVP are not features of pneumonia.
Pathophysiology in This Case
Previous MI → damaged myocardium → reduced ejection fraction → back-pressure builds up:
- Left-sided failure → pulmonary venous hypertension → bibasal crackles, dyspnea, cough
- Right-sided failure → systemic venous congestion → raised JVP, bilateral pitting edema, fatigue
This is the classic presentation of biventricular (congestive) heart failure following ischemic heart disease.
Answer: B — Congestive Heart Failure
Do the same
Answer: B. Neuroleptic Malignant Syndrome (NMS)
Systematic Reasoning
Key drug on board: Haloperidol — a typical (first-generation) antipsychotic, a potent D2 dopamine receptor antagonist. This is the critical clue.
| Finding | Significance |
|---|---|
| Fever 105°F (hyperthermia) | Hypothalamic dopamine blockade → loss of thermoregulation |
| Lead-pipe rigidity | Dopamine blockade in nigrostriatal pathway → severe extrapyramidal rigidity |
| Tremor | Extrapyramidal dysfunction |
| Delirium (altered consciousness) | CNS dopaminergic disruption |
| On haloperidol | Classic causative agent for NMS |
The classic NMS tetrad:
"FALTER" — Fever + Altered mental status + Lead-pipe rigidity + autonomic instability + Elevated CK (rhabdomyolysis)
Why this is NOT the others
| Option | Why it's wrong |
|---|---|
| A. Serotonin Syndrome | Sertraline (SSRI) is present, making this tempting — BUT serotonin syndrome causes hyperreflexia, clonus, myoclonus, and agitation, NOT lead-pipe rigidity. Also, onset is rapid (hours), and the dominant drug here is haloperidol. Rigidity + haloperidol = NMS. |
| C. Malignant hyperthermia | Triggered by inhaled anesthetic agents (e.g., halothane, succinylcholine). No surgical/anesthetic exposure mentioned. |
| D. Meningitis | Causes fever + delirium but also nuchal rigidity, photophobia, rash. Not drug-related. Lead-pipe rigidity ≠ meningismus. |
NMS vs. Serotonin Syndrome — The Critical Distinction
| Feature | NMS | Serotonin Syndrome |
|---|---|---|
| Cause | Antipsychotics (D2 blockers) | Serotonergic drugs (SSRIs, MAOIs, etc.) |
| Onset | Days–weeks | Hours |
| Rigidity | Lead-pipe (severe) | Mild or absent |
| Reflexes | Normal/decreased | Hyperreflexia, clonus |
| Movements | Bradykinesia | Myoclonus, tremor |
| Fever | High | Moderate–high |
The lead-pipe rigidity + haloperidol use clinches this as NMS, not serotonin syndrome — even though sertraline is co-prescribed.
Management of NMS (for completeness)
- Stop the offending antipsychotic immediately
- Supportive care: IV fluids, cooling measures
- Bromocriptine (dopamine agonist) or Dantrolene (muscle relaxant)
- Benzodiazepines for agitation
Answer: B — Neuroleptic Malignant Syndrome (NMS)
Do the same
Answer: D. Purine Nucleotides
Identifying the Reaction
Step 1 — Read the diagram:
| Structure | Identity |
|---|---|
| Top molecule | Ribose-5-phosphate with a pyrophosphate at C1 → PRPP (5-Phosphoribosyl-1-pyrophosphate) |
| Reaction ① | Glutamine donates an amino group (→ Glutamate + PPi released) |
| Bottom molecule | Ribose-5-phosphate with an NH₂ at C1 → 5-Phosphoribosylamine (PRA) |
This is the first committed step of de novo purine synthesis:
PRPP + Glutamine → 5-Phosphoribosylamine + Glutamate + PPi
Catalyzed by: Glutamine phosphoribosylpyrophosphate amidotransferase (also called PRPP amidotransferase / amidophosphoribosyltransferase)
Why Feedback Inhibition Here = Control of Purine Synthesis
This enzyme is the rate-limiting, committed step of the purine de novo pathway. It is subject to feedback inhibition by the end products of purine synthesis:
- AMP (adenosine monophosphate)
- GMP (guanosine monophosphate)
- IMP (inosine monophosphate)
When purine nucleotides accumulate, they inhibit this enzyme → synthesis shuts down. This is classic end-product feedback inhibition.
Why the Other Options Are Wrong
| Option | Why it's wrong |
|---|---|
| A. Complex carbohydrates | Synthesized via sugar-nucleotide pathways (e.g., UDP-glucose); PRPP is not involved |
| B. Folates | Folate synthesis uses PABA + pteridine; no PRPP/glutamine step |
| C. Pentose phosphates | The pentose phosphate pathway produces ribose-5-phosphate (the precursor to PRPP), but this reaction is not part of its synthesis or control |
| E. Pyrimidine nucleotides | De novo pyrimidine synthesis starts with carbamoyl phosphate + aspartate — the ring is built FIRST, then attached to PRPP. This reaction (PRPP → PRA via glutamine) is purine-specific |
The Key Distinguisher: Purine vs. Pyrimidine De Novo Synthesis
| Purines | Pyrimidines | |
|---|---|---|
| Strategy | Build ring on PRPP | Build ring first, attach to PRPP later |
| First committed step | PRPP + Glutamine → PRA ✅ | Carbamoyl phosphate synthetase II |
| Rate-limiting enzyme | PRPP amidotransferase | CPS II (inhibited by UTP) |
| Feedback inhibitors | AMP, GMP, IMP | UTP, CTP |
The NH₂ transfer from glutamine onto the ribose-phosphate scaffold is the definitive hallmark of the first step of purine de novo synthesis.
Answer: D — Purine Nucleotides
Do the same
Answer: C. Chronic Radiation Enteritis
Systematic Reasoning
The single most important clue: Prior pelvic radiotherapy for endometrial cancer — this contextualizes everything.
| Finding | Significance |
|---|---|
| 57-year-old woman | Post-treatment cancer surveillance age group |
| Prior radiotherapy for endometrial cancer | Pelvic radiation directly damages small bowel and colon (sigmoid, rectum most vulnerable) |
| Abdominal pain | Radiation-induced fibrosis, dysmotility, strictures |
| Vomiting | Partial obstruction or dysmotility from fibrotic bowel |
| Diarrhea | Malabsorption, bile salt dysfunction, bacterial overgrowth from damaged mucosa |
Pathophysiology of Chronic Radiation Enteritis
Pelvic radiation causes a progressive obliterative endarteritis (small vessel damage) in the bowel wall, leading to:
- Mucosal ischemia → atrophy, ulceration
- Submucosal fibrosis → strictures, obstruction
- Dysmotility → bacterial overgrowth → malabsorption, diarrhea
- Fistula formation (entero-enteric, entero-vesical, recto-vaginal)
Timing: Chronic radiation enteritis occurs months to years after radiation (vs. acute injury which occurs during/immediately after treatment). A 57-year-old with prior radiotherapy fits this chronic picture perfectly.
Why the Other Options Are Wrong
| Option | Why it's wrong |
|---|---|
| A. Crohn's disease | Typically presents in younger patients (15–35 yrs); characterized by skip lesions, transmural inflammation, perianal disease. No prior radiation needed. No mention of family history or typical Crohn's features. |
| B. Ulcerative colitis | Affects colon only (continuous, mucosal), presents with bloody diarrhea, typically younger age of onset. Not triggered by radiation history. |
| D. Irritable bowel syndrome (IBS) | A functional disorder (no structural/organic pathology). It does NOT cause vomiting as a primary feature, and crucially, it is a diagnosis of exclusion — never the answer when a clear organic cause (radiation) is present. |
Radiation Enteritis vs. Mimics — Quick Comparison
| Feature | Radiation Enteritis | Crohn's | UC | IBS |
|---|---|---|---|---|
| Cause | Pelvic RT | Autoimmune | Autoimmune | Functional |
| Age | Any (post-RT) | Young adult | Young adult | Young adult |
| Bloody diarrhea | Possible | Yes | Yes (hallmark) | No |
| Vomiting | Yes (obstruction) | Yes | Rare | Rare |
| Imaging | Strictures, fibrosis | Skip lesions | Continuous | Normal |
| Key clue | Prior RT history | Perianal disease | Rectal involvement | Stress-related |
Organs at Risk in Pelvic RT (for endometrial cancer)
The radiation field for endometrial cancer (pelvis) directly irradiates:
- Terminal ileum (small bowel loops in pelvis)
- Sigmoid colon
- Rectum
These are the most commonly injured segments, explaining the GI symptoms perfectly.
Answer: C — Chronic Radiation Enteritis
This is a shared conversation. Sign in to Orris to start your own chat.